This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,601 Years Active: 2006
Title: Innovations of Søren Brøgger Christensen
Introduction
Søren Brøgger Christensen is a notable inventor based in Nivaa, Denmark. He has made significant contributions to the field of anti-inflammatory agents through his innovative research and patent.
Latest Patents
Christensen holds a patent for the "Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents." This patent includes glycosides of diacylglycerol, specifically 3-β-D-galactopyranosyloxy-2-(octadeca-9Z,12Z,15Z-trienoyloxy)propanyl octadeca-9Z,12Z,15Z-trienoate (GOPO). This compound was isolated from extracts of rose-hips using activity-guided fractionation. It has potential applications as an oral anti-inflammatory agent for treating inflammatory diseases such as arthritis and osteoarthrosis.
Career Highlights
Throughout his career, Søren Brøgger Christensen has focused on developing innovative solutions in the field of medicinal chemistry. His work has led to advancements in the treatment of inflammatory conditions, showcasing his commitment to improving health outcomes.
Collaborations
Christensen has collaborated with notable colleagues, including Lars Porskjær Christensen and Arsalan Kharazmi. These partnerships have contributed to the success of his research and the development of his patented inventions.
Conclusion
Søren Brøgger Christensen's contributions to the field of anti-inflammatory agents highlight his innovative spirit and dedication to advancing medical science. His patent serves as a testament to his impactful work in addressing inflammatory diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile